Medline Inc. priced a secondary offering of 60,000,000 shares of its Class A common stock at $35.50 per share. The shares are being sold by investors affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC, GIC Private Limited and its managed affiliate, and a wholly owned subsidiary of the Abu Dhabi Investment Authority. Medline is not selling shares in the offering and will not receive proceeds. The selling stockholders granted underwriters a 30-day option to buy up to 9,000,000 additional shares, and the transaction is expected to close on November 23, 2026, subject to customary conditions. Separately, Medline and Medline Holdings, LP agreed to repurchase $200 million of Medline Class A common stock and Medline Holdings limited partnership interests in a private transaction at the offering price. The repurchase is expected to close concurrently with the offering, depends on the offering closing, and will count toward Medline's previously announced share repurchase program.